Clinical Research Advantage Opens New Clinical Research Site in South Carolina

TEMPE, Ariz. - March 17, 2014 - PRLog -- Clinical Research Advantage (CRA), the country’s largest wholly owned network of clinical trial sites, is excited to announce the addition of a new clinical research site in Anderson, SC. CRA has partnered with Primary Care Associates to open the site, which is located at 2000 E. Greenville Street (Suite 1600).  The site’s principal investigator is Harry I. Geisberg, MD.

CRA is a community-based site network that teams up with local physicians to set up clinical research sites within established medical offices. By partnering with community practices, CRA is able to facilitate the rapid recruitment of reliable and qualified trial participants. The partnerships also foster a higher level of study compliance, as CRA’s partner physicians give participants expert medical attention during the trial.

CRA staffs each clinical research office with its highly trained clinical research coordinators, research assistants and other research professionals. The staff members work with the physician to conduct the clinical trial with patient safety as the top priority. This includes providing coordination and regulatory support, and a full execution of the protocol with complete and accurate data.

To learn more about studies taking place at this site, call 1-855-4-A-STUDY (1-855-427-8839) or visithttp://crastudies.com/content/p/upcomingstudies.

About Clinical Research Advantage

Tempe, Arizona-based Clinical Research Advantage, Inc. (CRA) is the country’s largest wholly owned network of clinical trial sites. CRA works with pharmaceutical companies and contract research organizations to perform clinical trials for pharmaceuticals, vaccines and medical devices. The services provided by CRA allow trial sponsors to bring medical advancements to market quickly and efficiently. Founded in 1992, CRA acquired Radiant Research in 2012 and Comprehensive Clinical Development in 2013. Combined, the companies have successfully completed more than 11,000 clinical trials. For more information, please visit www.crastudies.com.